Israel Englander’s Hims & Hers Health HIMS Stock Holding History

Israel Englander’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.9M	Sell	517,700 -169,200	-25%	-$4.54M	0.01%	1717
2026 Q1	$14.3M	Buy	686,900 +393,100	+134%	+$9.29M	0.01%	1835
2025 Q4	$9.54M	Sell	293,800 -772,500	-72%	-$33.1M	﹤0.01%	2321
2025 Q3	$60.5M	Buy	1,066,300 +561,800	+111%	+$28.8M	0.03%	736
2025 Q2	$25.1M	Sell	504,500 -280,500	-36%	-$12.7M	0.01%	1359
2025 Q1	$23.2M	Buy	785,000 +709,000	+933%	+$26.3M	0.01%	1376
2024 Q4	$1.84M	Sell	76,000 -44,600	-37%	-$1.1M	﹤0.01%	3715
2024 Q3	$2.22M	Sell	120,600 -82,800	-41%	-$1.48M	﹤0.01%	3616
2024 Q2	$4.11M	Buy	203,400 +123,400	+154%	+$2.05M	﹤0.01%	2897
2024 Q1	$1.24M	Buy	+80,000	New	+$902K	﹤0.01%	4123

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Israel Englander's HIMS Position: Q2 2026 in Review

Israel Englander sold out of Hims & Hers Health (HIMS) in Q2 2026, closing a stake of 169,672 shares — an estimated $4.55M sold.

Israel Englander first reported a position in HIMS in Q4 2019 and held it in 25 quarters. The position peaked at $39.8M in Q2 2024. 504 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

Israel Englander reported no remaining Hims & Hers Health position as of Q2 2026 after selling out during the quarter.
Israel Englander sold 169,672 Hims & Hers Health shares in Q2 2026, an estimated $4.55M.
Israel Englander first reported a position in Hims & Hers Health in Q4 2019 and held it in 25 quarters.
Israel Englander's Hims & Hers Health position peaked at $39.8M in Q2 2024.
504 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.